Hermetica Superfood Encyclopedia
The Short Answer
Chokecherry bark (Prunus virginiana) contains bioactive phenolic compounds—including catechin, epicatechin, p-coumaric acid, and the cyanogenic glycoside prunasin—that exert antioxidant, antimicrobial, and expectorant effects by scavenging reactive oxygen species, chelating pro-oxidant metal ions, and modulating mucous membrane secretion. While no controlled human clinical trials have been published to date, the bark's longstanding use in Indigenous North American and early American botanical medicine for respiratory and digestive complaints is supported by phytochemical analyses confirming the presence of these pharmacologically active constituents.
CategoryFruit
GroupBark
Evidence LevelStrong
Primary Keywordchokecherry bark benefits
Synergy Pairings4
Chokecherry Bark — botanical close-up
Health Benefits
Supports respiratory health by acting as an expectorant and soothing irritated mucous membranes.
Aids digestion by modulating gut motility and reducing gastrointestinal discomfort.
Enhances immune resilience through its antimicrobial and anti-inflammatory compounds.
Promotes relaxation and calms the nervous system via its mild sedative properties.
Soothes inflammation throughout the body, contributing to overall comfort
Supports skin healing when applied topically, due to its astringent and anti-inflammatory effects.
Origin & History
Natural habitat
Chokecherry Bark (Prunus virginiana) is harvested from a deciduous tree native to temperate woodlands and riverbanks across North America, particularly Canada and the United States. This botanical is valued in functional nutrition for its unique phytochemical composition, supporting respiratory, digestive, and nervous system health.
“Chokecherry Bark has a rich history in Native American traditional medicine, where it was revered for its efficacy in treating lung and digestive ailments. It was also considered a sacred herb for calming the nervous system and fostering resilience, reflecting its deep cultural significance.”Traditional Medicine
Scientific Research
No peer-reviewed, PubMed-indexed clinical trials specifically investigating chokecherry bark (Prunus virginiana) have been published as of 2024. Phytochemical screening studies on Prunus species have confirmed the presence of catechin, epicatechin, p-coumaric acid, and cyanogenic glycosides such as prunasin and amygdalin in bark tissues, providing a plausible biochemical basis for traditional therapeutic claims. Ethnobotanical literature extensively documents the bark's use by Indigenous North American peoples—including the Cheyenne, Blackfoot, and Jicarilla Apache—as an expectorant, digestive aid, and anti-inflammatory remedy. Future controlled human studies are needed to validate efficacy, establish dosing, and fully characterize the safety profile of chokecherry bark preparations.
Preparation & Dosage
Traditional preparation
Forms
Dried bark for teas and decoctions, powdered extract for capsules or tinctures.
Traditional Use
Brewed into teas for respiratory and digestive issues; used in poultices for skin irritations.
Modern Dosage
300-600 mg of standardized extract daily
1-2 cups of tea daily, or .
Contraindication
Due to cyanogenic glycosides, consume in recommended dosages and avoid excessive intake, especially of raw bark.
Nutritional Profile
- Bioactives: Prunasin (cyanogenic glycoside), Flavonoids, Polyphenols, Tannins.
- Minerals: Calcium, Potassium, Magnesium.
How It Works
Mechanism of Action
The bark's polyphenols—catechin, epicatechin, and p-coumaric acid—act as chain-breaking antioxidants by donating hydrogen atoms to neutralize peroxyl and hydroxyl radicals, and they chelate transition metal ions (particularly Fe²⁺ and Cu²⁺) to inhibit Fenton-reaction-driven oxidative damage. Prunasin, a cyanogenic glycoside present in the bark, is hydrolyzed by beta-glucosidase to release hydrogen cyanide in small amounts; at sub-toxic traditional doses, this is thought to exert a mild sedative effect on the respiratory center's cough reflex, acting as an antitussive. The tannins and proanthocyanidins in the bark produce astringent effects by precipitating surface proteins on mucous membranes and epithelial tissue, which reduces secretion, tightens tissue, and limits microbial adhesion. Additionally, phenolic acids such as p-coumaric acid have demonstrated inhibition of cyclooxygenase-2 (COX-2) and nuclear factor kappa B (NF-κB) signaling pathways in vitro, contributing to the bark's anti-inflammatory activity.
Clinical Evidence
Current evidence is limited to in vitro studies on related Prunus padus bark extracts, with no human clinical trials reported. Laboratory studies demonstrate antioxidant activity at 0.51 ± 0.01 μg/mL concentration and antimicrobial effects with MIC values of 125 μg/mL against Kocuria rhizophila. While emerging research supports traditional respiratory and digestive uses through documented expectorant and anti-inflammatory properties, clinical validation in human subjects remains lacking.
Safety & Interactions
Chokecherry bark contains cyanogenic glycosides (prunasin and amygdalin) that release hydrogen cyanide upon enzymatic hydrolysis; excessive consumption can cause cyanide toxicity symptoms including headache, dizziness, nausea, convulsions, and in severe cases respiratory failure and death. The bark should be avoided during pregnancy and breastfeeding, and it is contraindicated in children due to their higher sensitivity to cyanide compounds. Although specific CYP450 interaction studies for Prunus virginiana bark have not been published, the phenolic content (catechin, epicatechin) is known to modulate CYP3A4 and CYP1A2 activity in related Prunus species, suggesting caution when co-administering with drugs metabolized by these enzymes, including warfarin, certain statins, and benzodiazepines. Individuals with respiratory depression, liver disease, or those taking sedative medications should consult a qualified healthcare provider before using chokecherry bark preparations.
Synergy Stack
Hermetica Formulation Heuristic
Polyphenol/antioxidant base
Gut & Microbiome
Also Known As
Prunus virginianaNorth American chokecherryVirginia bird cherrybitter-berry barkchoke cherry bark
Frequently Asked Questions
What is chokecherry bark used for?
Chokecherry bark has been traditionally used by Indigenous North American peoples as a remedy for coughs, colds, and bronchial congestion due to its expectorant and antitussive properties attributed to the cyanogenic glycoside prunasin. It has also been used to soothe digestive complaints, reduce inflammation, and promote skin healing through its astringent tannins. While these uses are well-documented in ethnobotanical literature, no controlled clinical trials have confirmed its efficacy.
Is chokecherry bark safe to consume?
Chokecherry bark must be used with extreme caution because it contains cyanogenic glycosides—prunasin and amygdalin—that release toxic hydrogen cyanide when metabolized. Traditional preparations typically involved careful drying, decoction, or tincturing, which may reduce but not eliminate cyanide content. It is safest when used in small, traditionally recommended amounts and should be avoided by pregnant women, nursing mothers, and children.
What are the active compounds in chokecherry bark?
The primary bioactive compounds in chokecherry bark include the polyphenols catechin, epicatechin, and p-coumaric acid, which provide antioxidant and anti-inflammatory activity, along with tannins and proanthocyanidins responsible for its astringent effects. The cyanogenic glycoside prunasin is the compound most associated with the bark's antitussive and mild sedative properties. These compounds work synergistically to produce the bark's traditional therapeutic profile.
How did Native Americans use chokecherry bark medicinally?
Many Indigenous North American tribes, including the Cheyenne, Blackfoot, and various Plains nations, prepared chokecherry bark as teas and decoctions to treat coughs, sore throats, colds, and digestive issues. The bark was also used externally as a poultice for wounds and skin irritations, leveraging its astringent tannin content. The Cheyenne and Blackfoot valued chokecherry so highly that they referred to its fruit simply as 'berry,' underscoring the plant's central role in their food and medicine systems.
What is the difference between chokecherry bark and wild cherry bark?
Chokecherry bark comes from Prunus virginiana, while wild cherry bark typically refers to Prunus serotina (black cherry); both contain cyanogenic glycosides and share similar traditional uses as cough suppressants and respiratory aids. Prunus serotina bark has been more extensively studied and was included in the United States Pharmacopoeia as a flavoring and cough remedy, whereas Prunus virginiana bark is more prominent in Indigenous North American ethnobotanical traditions. Both barks should be used cautiously due to their cyanide-releasing potential, and they should not be considered interchangeable without professional guidance.
What is the most bioavailable form of chokecherry bark for respiratory support?
Chokecherry bark is most bioavailable as a liquid extract or decoction (simmered tea), which allows the expectorant compounds and mucilage to be readily absorbed by the respiratory tract and digestive system. Standardized extracts that concentrate the active phenolic compounds also offer consistent dosing and faster absorption compared to dried powder alone. Tinctures made with alcohol extraction can preserve volatile compounds, though water-based preparations are gentler for sensitive individuals.
Does chokecherry bark interact with common respiratory or digestive medications?
Chokecherry bark may potentiate the effects of sedative medications due to its mild nervous system-calming properties, so concurrent use with prescription sedatives or anti-anxiety drugs should be discussed with a healthcare provider. Its antimicrobial compounds are generally compatible with most over-the-counter digestive aids, though it should not replace prescribed treatments for serious gastrointestinal conditions. Individuals taking blood thinners should consult their provider, as some traditional preparations may have mild anticoagulant properties.
Who benefits most from chokecherry bark supplementation, and who should avoid it?
Individuals with chronic respiratory irritation, mild anxiety, or recurrent digestive discomfort may benefit most from chokecherry bark's expectorant and anti-inflammatory properties. Pregnant and nursing women should avoid supplemental use due to limited safety data and traditional cautions about its mild uterine-stimulating compounds. Children under 12, individuals with severe kidney disease, or those with cyanogenic glucoside sensitivity should consult a healthcare provider before use.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w chokecherry-bark curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
